Stay updated on Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial page.

Latest updates to the Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference7%
- Check21 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.4%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.4%
- Check50 days agoChange DetectedThe web page has added significant details regarding the facility name and location, which are crucial for users seeking specific information about the study. Additionally, multiple updates on study status and outcome measures have been included, reflecting ongoing changes in the study's progress.SummaryDifference87%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial page.